Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly

被引：0
|
作者：
Te-Ling Ma
Wei-Chen Tai
Song-Seng Loke
Chih-Chien Yao
Chih-Ming Liang
Seng-Kee Chuah
机构：
[1] Fu Jen Catholic University Hospital,Department of Internal Medicine
[2] New Taipei City,Division of Hepato
[3] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Gastroenterology, Department of Internal Medicine
[4] Chang Gung University College of Medicine,Division of Family Physician
[5] Kaohsiung Chang Gung Memorial Hospital,undefined
来源：
Drugs & Aging | 2023年 / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 79
页数：8
相关论文
共 50 条
  • [1] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Ma, Te-Ling
    Tai, Wei-Chen
    Loke, Song-Seng
    Yao, Chih-Chien
    Liang, Chih-Ming
    Chuah, Seng-Kee
    [J]. DRUGS & AGING, 2023, 40 (01) : 71 - 79
  • [2] Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori
    Pereira, F.
    Azevedo, R.
    Linhares, M.
    Ramos, D.
    Pinto, J.
    Caldeira, A.
    Tristan, J.
    Pereira, E.
    Sousa, R.
    Banhudo, A.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [3] Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
    Gisbert, Javier P.
    Calvet, Xavier
    [J]. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 23 - 34
  • [4] Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication:A randomized study in Japan
    Ayako Yanai
    Kei Sakamoto
    Masao Akanuma
    Keiji Ogura
    Shin Maeda
    [J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (01) : 1 - 6
  • [5] Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication
    Ye, Jian Fang
    Hong, Jun Bo
    Zhu, Yin
    Xie, Yong
    Shu, Xu
    Luo, Ling Yu
    Xie, Chuan
    Zhu, Zhen Hua
    Lu, Nong Hua
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (12) : 704 - 708
  • [6] Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
    Hung, Kuo-Tung
    Yang, Shih-Cheng
    Wu, Cheng-Kun
    Wang, Hsing-Ming
    Yao, Chih-Chien
    Liang, Chih-Ming
    Tai, Wei-Chen
    Wu, Keng-Liang
    Kuo, Yuan-Hung
    Lee, Chen-Hsiang
    Chuah, Seng-Kee
    [J]. INFECTION AND DRUG RESISTANCE, 2021, 14 : 1239 - 1246
  • [7] Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy
    Alcedo, Javier
    Gracia, Marta
    Garcia-Camara, Paula
    Palacin, Carmen
    Gallego, Sonia
    Jimeno-Ayllon, Cristina
    Frago, Santiago
    Aured, Isabel
    Luzon, Lara
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (06): : 301 - 309
  • [8] SECOND-LINE HELICOBACTER PYLORI ERADICATION THERAPY AFTER FAILURE OF NON-BISMUTH QUADRUPLE "CONCOMITANT" TREATMENT
    Kim, S.
    Choe, J.
    Jung, S.
    Park, J.
    Chun, H.
    Lee, S.
    [J]. HELICOBACTER, 2015, 20 : 92 - 92
  • [9] BISMUTH VS NON-BISMUTH (CONCOMITANT) QUADRUPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Cominardi, A.
    Marasco, G.
    Russo, T.
    Cirota, G. G.
    Galloro, G.
    Romano, M.
    Bazzoli, F.
    Zagari, R. M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S13 - S13
  • [10] NON-BISMUTH QUADRUPLE (CONCOMITANT) THERAPY FOR ERADICATION OF HELICOBATER PYLORI: A SYSTEMATIC REVIEW
    Gisbert, J. P.
    Calvet, X.
    [J]. HELICOBACTER, 2011, 16 : 131 - 131
12345